Continuing GLP-1 RA use through surgery increases risk for surgical complications including aspiration and conversion to intubation ...

A large cohort study finds GLP-1 receptor agonists linked to lower graft loss and mortality in kidney transplant recipients ...

By December 2023, she had lost enough weight to qualify for knee replacement surgery. She now lives pain free and credits the results, in no small part, to her weight loss medication. GLP-1 drugs ...

In 2023, the United States marked a major milestone in the battle against a longstanding public health crisis: adult obesity rates dropped for the first time in a decade. Researchers pointed to GLP-1s ...

Eli Lilly is advancing its diabetes and obesity treatment with an oral drug, orforglipron. In an exclusive interaction, CEO ...

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

Many employers are facing challenges in incorporating high-cost GLP-1 medications, such as Mounjaro, Ozempic, Rybelsus, Trulicity, and Wegovy, ...

GLP-1 drugs, originally for type 2 diabetes ... Looking at the protocols for individuals undergoing bariatric surgery may offer ideas for next steps. When patients undergo bariatric surgery ...

“To minimize risks of delayed emergence from anesthesia, aspiration, aspiration pneumonitis, and conversion to intubation, ceasing GLP-1 RA 14 days before surgery is optimal,” the authors write.